Literature DB >> 24169933

[European guidelines on cardiovascular disease prevention. What has changed in 2012?].

H Gohlke1.   

Abstract

The new European Guidelines on Cardiovascular Disease Prevention (version 2012) are supported by nine medical societies. They are newly structured, shorter and more readable. Each subchapter starts with key messages and recommendations are labeled with an evidence level. The subchapter ends with "most important newest information" and "persisting gaps of evidence" for further research. Smoking and passive smoking are to be avoided, even a small amount of regular physical activity is beneficial, the Mediterranean type diet is recommended and a body mass index (BMI) between 22 and 25 is associated with the lowest mortality. A blood pressure target of <140/90 mmHg is appropriate for the vast majority of hypertensive patients. Aspirin is not recommended for primary prevention even not for diabetics without vascular disease. Cardiovascular risk is now categorized into four levels: low (<1%), medium (1% to <5%), high (5% to <10%) and very high risk (≥10%). All patients with cardiovascular disease are in the very high risk group with the corresponding treatment goals, e. g. a low density lipoprotein (LDL) cholesterol goal of <70 mg/dl (<1.8 mmol/l). Treatment adherence and behavioral changes can best be achieved by motivational interviews which demand some time. It is emphasized that the physician has the responsibility for clear recommendations in the discharge summaries after hospitalization and for offering help and feed back in the implementation phase of behavioral changes.

Entities:  

Mesh:

Year:  2013        PMID: 24169933     DOI: 10.1007/s00059-013-3974-0

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  15 in total

1.  [Primary prevention of coronary artery disease: is there a role for risk scores?].

Authors:  H Gohlke
Journal:  Herz       Date:  2012-02       Impact factor: 1.443

Review 2.  Salt restriction for the prevention of cardiovascular disease.

Authors:  Dieter Klaus; Joachim Hoyer; Martin Middeke
Journal:  Dtsch Arztebl Int       Date:  2010-07-02       Impact factor: 5.594

3.  Primary prevention of cardiovascular disease with a Mediterranean diet.

Authors:  Ramón Estruch; Emilio Ros; Jordi Salas-Salvadó; Maria-Isabel Covas; Dolores Corella; Fernando Arós; Enrique Gómez-Gracia; Valentina Ruiz-Gutiérrez; Miquel Fiol; José Lapetra; Rosa Maria Lamuela-Raventos; Lluís Serra-Majem; Xavier Pintó; Josep Basora; Miguel Angel Muñoz; José V Sorlí; José Alfredo Martínez; Miguel Angel Martínez-González
Journal:  N Engl J Med       Date:  2013-02-25       Impact factor: 91.245

4.  Weight loss, exercise, or both and physical function in obese older adults.

Authors:  Dennis T Villareal; Suresh Chode; Nehu Parimi; David R Sinacore; Tiffany Hilton; Reina Armamento-Villareal; Nicola Napoli; Clifford Qualls; Krupa Shah
Journal:  N Engl J Med       Date:  2011-03-31       Impact factor: 91.245

5.  [Tobacco-attributable mortality in Germany and in the German Federal States - calculations with data from a microcensus and mortality statistics].

Authors:  U Mons
Journal:  Gesundheitswesen       Date:  2010-06-14

6.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Authors:  Zeljko Reiner; Alberico L Catapano; Guy De Backer; Ian Graham; Marja-Riitta Taskinen; Olov Wiklund; Stefan Agewall; Eduardo Alegria; M John Chapman; Paul Durrington; Serap Erdine; Julian Halcox; Richard Hobbs; John Kjekshus; Pasquale Perrone Filardi; Gabriele Riccardi; Robert F Storey; David Wood
Journal:  Eur Heart J       Date:  2011-06-28       Impact factor: 29.983

7.  Cardiovascular prevention in clinical practice (ESC and German guidelines 2007).

Authors:  Helmut Gohlke; Christian Albus; Detlef Bernd Gysan; Harry W Hahmann; Peter Mathes
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

8.  Association between smoke-free legislation and hospitalizations for cardiac, cerebrovascular, and respiratory diseases: a meta-analysis.

Authors:  Crystal E Tan; Stanton A Glantz
Journal:  Circulation       Date:  2012-10-30       Impact factor: 29.690

9.  Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.

Authors:  Colin Baigent; Lisa Blackwell; Rory Collins; Jonathan Emberson; Jon Godwin; Richard Peto; Julie Buring; Charles Hennekens; Patricia Kearney; Tom Meade; Carlo Patrono; Maria Carla Roncaglioni; Alberto Zanchetti
Journal:  Lancet       Date:  2009-05-30       Impact factor: 79.321

Review 10.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors:  Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal:  BMJ       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.